AI Breakdown Meta to Layoff 20%, AI Cured Dogs Cancer, Nvidia's New Chip
Mar 16, 2026
A personalized mRNA cancer vaccine for a dog built with AI tools gets spotlighted. NVIDIA's next-generation AI chip and its potential to reshape performance are previewed. Talks of a $10B enterprise AI rollout via private equity are explored. Large AI-driven workforce cuts at a major social platform and industrywide restructuring are discussed.
AI Snips
Chapters
Transcript
Episode notes
Engineer Uses AI To Save His Dog
- Paul Conahan used ChatGPT and AlphaFold with researchers to design a custom mRNA cancer vaccine for his dog Rosie after vets gave a grim prognosis.
- Rosie received the vaccine in December and by March her tumor shrank about 75%, a rapid personalized-medicine result.
NVIDIA Chips Will Drive Inference Boom
- NVIDIA's next-generation chips will reset performance ceilings and accelerate large-scale inference deployment across industries.
- Jaeden says the industry is shifting from training-focused to massive inference demand as models are deployed everywhere.
OpenAI Partners With PE To Scale Enterprise AI
- OpenAI exploring a $10B joint venture with TPG, Bain Capital, Advent, and Brookfield aims to roll AI into thousands of PE portfolio companies.
- The deal could include about $4B external investment and accelerate enterprise AI adoption via PE distribution.